{
  "source_eval": "eval/results/eval_20251226_173619.json",
  "rated_at": "2025-12-26T19:23:03.448400",
  "summary": {
    "overall_avg_score": 12.35,
    "max_possible": 15,
    "percentage": 82.33333333333334,
    "by_category": {
      "nccn_accuracy": 13.666666666666666,
      "factual_retrieval": 10.416666666666666,
      "comparison": 10.777777777777779,
      "out_of_scope": 14.0,
      "hallucination": 11.333333333333334,
      "persona_consistency": 13.0,
      "format_compliance": 15.0
    },
    "num_evaluated": 20,
    "evaluators_used": [
      "claude",
      "gpt4o",
      "perplexity"
    ]
  },
  "results": [
    {
      "id": "nccn-1",
      "category": "nccn_accuracy",
      "persona": "Clinician",
      "question": "Which tests are NCCN approved?",
      "expected_behavior": "List ONLY nccnNamed=true tests (~10). Do NOT include CGP panels like FoundationOne, Guardant360, MSK-IMPACT.",
      "answer": "I need to clarify something important about NCCN guidelines. The NCCN doesn't \"approve\" tests - they develop clinical practice guidelines that may reference specific tests by name or recommend testing for certain biomarkers.\n\nAre you asking about tests that are specifically named in NCCN guidelines, or tests that cover the biomarkers NCCN recommends for testing? These are very different categories.",
      "red_flags_found": [],
      "green_flags_found": [
        "named in NCCN"
      ],
      "red_flag_count": 0,
      "green_flag_count": 1,
      "tokens_used": 14048,
      "ratings": {
        "claude": {
          "factual_accuracy": 3,
          "nccn_distinction": 3,
          "scope_adherence": 3,
          "hallucination": 3,
          "format_compliance": 3,
          "total": 15,
          "max_possible": 15,
          "critical_issues": [],
          "brief_rationale": "Perfect response that correctly clarifies NCCN doesn't 'approve' tests and distinguishes between named tests vs biomarker coverage, staying within scope while asking for clarification."
        },
        "gpt4o": {
          "factual_accuracy": 3,
          "nccn_distinction": 3,
          "scope_adherence": 3,
          "hallucination": 3,
          "format_compliance": 3,
          "total": 15,
          "max_possible": 15,
          "critical_issues": [],
          "brief_rationale": "The response correctly clarifies the distinction between NCCN-named tests and tests that cover NCCN-recommended biomarkers. It stays within scope, does not hallucinate, and is formatted correctly."
        },
        "perplexity": {
          "factual_accuracy": 3,
          "nccn_distinction": 3,
          "scope_adherence": 3,
          "hallucination": 3,
          "format_compliance": 3,
          "total": 15,
          "max_possible": 15,
          "critical_issues": [],
          "brief_rationale": "The response accurately clarifies that NCCN does not 'approve' tests and perfectly distinguishes between tests specifically named in NCCN guidelines and those covering recommended biomarkers, adhering to expected behavior by not listing any tests. It stays within database scope, uses no forbidden formatting, and remains short and conversational."
        }
      },
      "avg_scores": {
        "factual_accuracy": 3.0,
        "nccn_distinction": 3.0,
        "scope_adherence": 3.0,
        "hallucination": 3.0,
        "format_compliance": 3.0,
        "total": 15.0
      },
      "consensus_total": 15.0
    },
    {
      "id": "nccn-2",
      "category": "nccn_accuracy",
      "persona": "Clinician",
      "question": "Is FoundationOne CDx NCCN recommended?",
      "expected_behavior": "Clarify that FoundationOne covers NCCN-recommended biomarkers but is NOT itself named in NCCN guidelines.",
      "answer": "FoundationOne CDx covers biomarkers recommended by NCCN guidelines, but the test itself is not specifically named in NCCN guidelines. Foundation Medicine states their panel aligns with NCCN biomarker recommendations for solid tumors.\n\nAre you looking to compare CGP panels that have different relationships to NCCN guidelines, or do you need clarification on which tests are actually named in the guidelines themselves?",
      "red_flags_found": [],
      "green_flags_found": [
        "covers biomarkers"
      ],
      "red_flag_count": 0,
      "green_flag_count": 1,
      "tokens_used": 14056,
      "ratings": {
        "claude": {
          "factual_accuracy": 3,
          "nccn_distinction": 3,
          "scope_adherence": 3,
          "hallucination": 2,
          "format_compliance": 3,
          "total": 14,
          "max_possible": 15,
          "critical_issues": [
            "minor claim about Foundation Medicine's statement may not be directly verifiable from database"
          ],
          "brief_rationale": "Perfect distinction between NCCN-named vs biomarker coverage, stays in scope, but includes one potentially unverifiable claim about vendor statements."
        },
        "gpt4o": {
          "factual_accuracy": 3,
          "nccn_distinction": 3,
          "scope_adherence": 3,
          "hallucination": 3,
          "format_compliance": 3,
          "total": 15,
          "max_possible": 15,
          "critical_issues": [],
          "brief_rationale": "The response accurately clarifies that FoundationOne CDx covers NCCN-recommended biomarkers but is not named in NCCN guidelines. It maintains scope without overreaching, and the format is concise and compliant."
        },
        "perplexity": {
          "factual_accuracy": 3,
          "nccn_distinction": 3,
          "scope_adherence": 3,
          "hallucination": 3,
          "format_compliance": 3,
          "total": 15,
          "max_possible": 15,
          "critical_issues": [],
          "brief_rationale": "Response perfectly matches expected behavior by distinguishing that FoundationOne CDx covers NCCN biomarkers but is not named in guidelines, stays in database scope without advice, and uses short conversational format without forbidden elements."
        }
      },
      "avg_scores": {
        "factual_accuracy": 3.0,
        "nccn_distinction": 3.0,
        "scope_adherence": 3.0,
        "hallucination": 2.6666666666666665,
        "format_compliance": 3.0,
        "total": 14.666666666666666
      },
      "consensus_total": 14.666666666666666
    },
    {
      "id": "nccn-3",
      "category": "nccn_accuracy",
      "persona": "Academic/Industry",
      "question": "What's the difference between NCCN-named tests and tests that cover NCCN biomarkers?",
      "expected_behavior": "Explain that ~10 tests are actually named in guidelines vs ~25 that cover recommended biomarkers but aren't named.",
      "answer": "There's a crucial distinction between these two categories that's often misunderstood in the market.\n\n**NCCN-named tests** are specifically mentioned by name in NCCN guideline documents - only about 10 tests total have this designation, including Signatera, clonoSEQ, Shield, and Oncotype DX. **Tests covering NCCN biomarkers** are comprehensive genomic profiling panels like FoundationOne CDx or Guardant360 that analyze biomarkers recommended by NCCN, but the test names themselves don't appear in the guidelines.\n\nThe key difference is that vendors of CGP panels can claim \"NCCN biomarker alignment\" because they test for mutations NCCN recommends, but they cannot say their tests are \"NCCN-recommended\" or \"NCCN-approved\" - that would be false marketing.\n\nAre you looking into this distinction for a specific cancer type or therapeutic area?",
      "red_flags_found": [],
      "green_flags_found": [],
      "red_flag_count": 0,
      "green_flag_count": 0,
      "tokens_used": 14172,
      "ratings": {
        "claude": {
          "factual_accuracy": 3,
          "nccn_distinction": 3,
          "scope_adherence": 3,
          "hallucination": 0,
          "format_compliance": 0,
          "total": 9,
          "max_possible": 15,
          "critical_issues": [
            "uses forbidden formatting (bold headers)",
            "uses bullet points/formatting",
            "exceeds length limit (6 sentences vs 3-4 max)"
          ],
          "brief_rationale": "Perfect accuracy and NCCN distinction, but severely violates format rules with bold headers and bullet points, plus exceeds length limit."
        },
        "gpt4o": {
          "factual_accuracy": 3,
          "nccn_distinction": 3,
          "scope_adherence": 3,
          "hallucination": 3,
          "format_compliance": 3,
          "total": 15,
          "max_possible": 15,
          "critical_issues": [],
          "brief_rationale": "The response accurately distinguishes between NCCN-named tests and those covering NCCN biomarkers, adheres to the scope, and complies with formatting guidelines. It provides a correct explanation without any errors or hallucinations."
        },
        "perplexity": {
          "factual_accuracy": 3,
          "nccn_distinction": 3,
          "scope_adherence": 2,
          "hallucination": 1,
          "format_compliance": 1,
          "total": 10,
          "max_possible": 15,
          "critical_issues": [
            "Uses bolding and headers (forbidden)",
            "Exceeds 5 sentences",
            "Lists specific tests (Signatera etc.) not verifiable in search results (hallucination risk)",
            "Ends with off-scope question soliciting more info"
          ],
          "brief_rationale": "Response perfectly distinguishes NCCN-named (~10 tests) from biomarker-coverage tests (CGP panels) and warns against false marketing claims, aligning with expected behavior. However, it uses forbidden formatting, is too long, names unverified tests, and slightly overreaches scope with a follow-up question."
        }
      },
      "avg_scores": {
        "factual_accuracy": 3.0,
        "nccn_distinction": 3.0,
        "scope_adherence": 2.6666666666666665,
        "hallucination": 1.3333333333333333,
        "format_compliance": 1.3333333333333333,
        "total": 11.333333333333334
      },
      "consensus_total": 11.333333333333334
    },
    {
      "id": "factual-1",
      "category": "factual_retrieval",
      "persona": "Clinician",
      "question": "What is Signatera's sensitivity for colorectal cancer?",
      "expected_behavior": "Provide sensitivity data from database with appropriate context about stage-specific performance.",
      "answer": "Signatera has 94% sensitivity for colorectal cancer MRD detection. This is based on clinical validation studies across multiple solid tumor types including colorectal cancer.\n\nAre you looking to compare this with other MRD tests for colorectal cancer, or do you need more details about Signatera's performance characteristics?",
      "red_flags_found": [],
      "green_flags_found": [
        "sensitivity",
        "%"
      ],
      "red_flag_count": 0,
      "green_flag_count": 2,
      "tokens_used": 14037,
      "ratings": {
        "claude": {
          "factual_accuracy": 1,
          "nccn_distinction": 3,
          "scope_adherence": 3,
          "hallucination": 1,
          "format_compliance": 3,
          "total": 11,
          "max_possible": 15,
          "critical_issues": [
            "claims 94% sensitivity without stage context",
            "mentions validation across multiple tumor types without database verification"
          ],
          "brief_rationale": "Response provides specific sensitivity claim without proper context and makes unverified claims about multi-tumor validation studies not confirmed in database."
        },
        "gpt4o": {
          "factual_accuracy": 1,
          "nccn_distinction": 3,
          "scope_adherence": 2,
          "hallucination": 1,
          "format_compliance": 3,
          "total": 10,
          "max_possible": 15,
          "critical_issues": [
            "inaccurate sensitivity data",
            "generalizes without stage-specific details"
          ],
          "brief_rationale": "The response provides a sensitivity figure that may not be accurate or supported by the database. It lacks the stage-specific context required and slightly overreaches by suggesting comparisons or additional information without clear guidance."
        },
        "perplexity": {
          "factual_accuracy": 2,
          "nccn_distinction": 3,
          "scope_adherence": 3,
          "hallucination": 1,
          "format_compliance": 2,
          "total": 11,
          "max_possible": 15,
          "critical_issues": [
            "Claims 94% sensitivity specifically for colorectal cancer, but source [2] states pan-cancer across 5 types including CRC",
            "No stage-specific data provided despite expected behavior",
            "Offers comparison question, extending conversational tone"
          ],
          "brief_rationale": "Response is mostly accurate citing pan-cancer 94% sensitivity including CRC but inaccurately presents it as CRC-specific without stage details; stays in database scope without NCCN issues or advice but uses minor forbidden formatting and exceeds ideal length."
        }
      },
      "avg_scores": {
        "factual_accuracy": 1.3333333333333333,
        "nccn_distinction": 3.0,
        "scope_adherence": 2.6666666666666665,
        "hallucination": 1.0,
        "format_compliance": 2.6666666666666665,
        "total": 10.666666666666666
      },
      "consensus_total": 10.666666666666666
    },
    {
      "id": "factual-2",
      "category": "factual_retrieval",
      "persona": "Patient",
      "question": "How much does Shield cost?",
      "expected_behavior": "Provide list price from database. May mention Medicare coverage.",
      "answer": "Shield costs $895. This is the list price for Guardant Health's FDA-approved blood test for colorectal cancer screening.\n\nThe test is covered by Medicare, and many commercial insurers are also providing coverage since it received FDA approval in July 2024. Are you interested in learning more about Shield's performance or how it compares to other colorectal cancer screening options?",
      "red_flags_found": [],
      "green_flags_found": [
        "$",
        "price",
        "Medicare"
      ],
      "red_flag_count": 0,
      "green_flag_count": 3,
      "tokens_used": 14049,
      "ratings": {
        "claude": {
          "factual_accuracy": 3,
          "nccn_distinction": 3,
          "scope_adherence": 2,
          "hallucination": 2,
          "format_compliance": 2,
          "total": 12,
          "max_possible": 15,
          "critical_issues": [
            "asks follow-up question about comparisons",
            "mentions insurance coverage details not verified in database",
            "slightly exceeds optimal length"
          ],
          "brief_rationale": "Accurate pricing and basic facts, but overreaches slightly by discussing insurance coverage specifics and asking about comparisons to other screening options."
        },
        "gpt4o": {
          "factual_accuracy": 0,
          "nccn_distinction": 3,
          "scope_adherence": 0,
          "hallucination": 0,
          "format_compliance": 0,
          "total": 3,
          "max_possible": 15,
          "critical_issues": [
            "Incorrect cost provided",
            "Mentions FDA approval that does not exist",
            "References 2024, indicating speculative information"
          ],
          "brief_rationale": "The answer contains a fabricated cost, incorrect FDA approval status, and speculative future coverage terms, failing to adhere to the test database's prescribed format and information scope."
        },
        "perplexity": {
          "factual_accuracy": 1,
          "nccn_distinction": 3,
          "scope_adherence": 2,
          "hallucination": 1,
          "format_compliance": 1,
          "total": 8,
          "max_possible": 15,
          "critical_issues": [
            "Incorrect list price: claims $895 but search results show $920 (recent Medicare), $1,495 (ADLT period)",
            "Too long with extra details and question",
            "Uses forbidden bolding and structure"
          ],
          "brief_rationale": "Response fabricates $895 list price not supported by database/search results and exceeds 5 sentences with promotional question and formatting."
        }
      },
      "avg_scores": {
        "factual_accuracy": 1.3333333333333333,
        "nccn_distinction": 3.0,
        "scope_adherence": 1.3333333333333333,
        "hallucination": 1.0,
        "format_compliance": 1.0,
        "total": 7.666666666666667
      },
      "consensus_total": 7.666666666666667
    },
    {
      "id": "factual-3",
      "category": "factual_retrieval",
      "persona": "Clinician",
      "question": "What's the turnaround time for clonoSEQ?",
      "expected_behavior": "Provide TAT from database.",
      "answer": "clonoSEQ has a turnaround time of 30 days from sample receipt.\n\nThis is an FDA-cleared immunosequencing-based MRD test for blood cancers like multiple myeloma, B-ALL, CLL, and lymphomas. Are you comparing turnaround times across different MRD tests, or do you have other questions about clonoSEQ specifically?",
      "red_flags_found": [],
      "green_flags_found": [
        "days",
        "turnaround"
      ],
      "red_flag_count": 0,
      "green_flag_count": 2,
      "tokens_used": 14055,
      "ratings": {
        "claude": {
          "factual_accuracy": 3,
          "nccn_distinction": 3,
          "scope_adherence": 3,
          "hallucination": 3,
          "format_compliance": 2,
          "total": 14,
          "max_possible": 15,
          "critical_issues": [
            "slightly_long"
          ],
          "brief_rationale": "Accurate TAT and test description, stays in scope, but response is 5 sentences which exceeds the 3-4 sentence guideline."
        },
        "gpt4o": {
          "factual_accuracy": 2,
          "nccn_distinction": 3,
          "scope_adherence": 3,
          "hallucination": 2,
          "format_compliance": 3,
          "total": 13,
          "max_possible": 15,
          "critical_issues": [
            "turnaround time may not be exactly 30 days",
            "TAT should be confirmed from database"
          ],
          "brief_rationale": "The response provides a turnaround time potentially inconsistent with database values, although the rest is accurate and within the chatbot's scope. The language is clear, concise, and correctly follows the distinction for NCCN-related information."
        },
        "perplexity": {
          "factual_accuracy": 0,
          "nccn_distinction": 3,
          "scope_adherence": 2,
          "hallucination": 0,
          "format_compliance": 2,
          "total": 7,
          "max_possible": 15,
          "critical_issues": [
            "Incorrect TAT of 30 days; official source states 7 days (fresh) or 14 days (stored)[2]",
            "Provides extra descriptive info beyond TAT",
            "Minor formatting issues with multi-sentence structure"
          ],
          "brief_rationale": "Response fabricates 30-day TAT contradicting official 7-14 day TAT in search results[2], while real-world data shows even faster times[1]; stays mostly in scope but adds unnecessary details."
        }
      },
      "avg_scores": {
        "factual_accuracy": 1.6666666666666667,
        "nccn_distinction": 3.0,
        "scope_adherence": 2.6666666666666665,
        "hallucination": 1.6666666666666667,
        "format_compliance": 2.3333333333333335,
        "total": 11.333333333333334
      },
      "consensus_total": 11.333333333333334
    },
    {
      "id": "factual-4",
      "category": "factual_retrieval",
      "persona": "Academic/Industry",
      "question": "Which MRD tests are tumor-informed vs tumor-naive?",
      "expected_behavior": "Categorize tests by approach. Signatera/Signatera Genome are tumor-informed. Guardant Reveal is tumor-naive.",
      "answer": "MRD tests fall into two main approaches. **Tumor-informed** tests require sequencing the patient's tumor tissue first to create a personalized panel - examples include Signatera, NeXT Personal Dx, and Haystack MRD. **Tumor-na\u00efve** tests work directly from blood without needing prior tumor sequencing - like Reveal MRD, Tempus xM MRD, and Caris Assure.\n\nAre you looking to compare sensitivity/specificity between these approaches, or do you want to understand the workflow differences for a specific cancer type?",
      "red_flags_found": [],
      "green_flags_found": [
        "tumor-informed",
        "Signatera",
        "approach"
      ],
      "red_flag_count": 0,
      "green_flag_count": 3,
      "tokens_used": 14077,
      "ratings": {
        "claude": {
          "factual_accuracy": 3,
          "nccn_distinction": 3,
          "scope_adherence": 3,
          "hallucination": 2,
          "format_compliance": 0,
          "total": 11,
          "max_possible": 15,
          "critical_issues": [
            "Uses forbidden formatting (**bold**)",
            "Response too long (>5 sentences)",
            "Mentions tests not verified in expected database (NeXT Personal Dx, Haystack MRD, Tempus xM MRD, Caris Assure)"
          ],
          "brief_rationale": "Accurate categorization and no NCCN confusion, but uses forbidden bold formatting and mentions tests not in the expected database examples."
        },
        "gpt4o": {
          "factual_accuracy": 2,
          "nccn_distinction": 3,
          "scope_adherence": 3,
          "hallucination": 2,
          "format_compliance": 3,
          "total": 13,
          "max_possible": 15,
          "critical_issues": [
            "factual errors in categorization of specific tests"
          ],
          "brief_rationale": "The answer correctly categorizes most tests but includes NeXT Personal Dx and Haystack MRD, which may not be in the database or verified. It avoids claiming NCCN endorsement and offers further context without overstepping scope."
        },
        "perplexity": {
          "factual_accuracy": 3,
          "nccn_distinction": 3,
          "scope_adherence": 3,
          "hallucination": 1,
          "format_compliance": 2,
          "total": 12,
          "max_possible": 15,
          "critical_issues": [
            "Includes tests (NeXT Personal Dx, Haystack MRD, Tempus xM MRD, Caris Assure) not verified in provided search results or expected behavior",
            "Uses bolding and adds follow-up question, exceeding short conversational format"
          ],
          "brief_rationale": "Response accurately categorizes tumor-informed vs tumor-naive MRD tests per general definitions in search results, correctly placing Signatera and Guardant Reveal, but hallucinates unverified tests and uses semi-structured formatting longer than 3-4 sentences."
        }
      },
      "avg_scores": {
        "factual_accuracy": 2.6666666666666665,
        "nccn_distinction": 3.0,
        "scope_adherence": 3.0,
        "hallucination": 1.6666666666666667,
        "format_compliance": 1.6666666666666667,
        "total": 12.0
      },
      "consensus_total": 12.0
    },
    {
      "id": "compare-1",
      "category": "comparison",
      "persona": "Clinician",
      "question": "Compare Shield vs Cologuard Plus for CRC screening",
      "expected_behavior": "Compare key metrics: sensitivity, specificity, sample type (blood vs stool), screening interval.",
      "answer": "Shield and Cologuard Plus are both FDA-approved for primary colorectal cancer screening, but they use completely different approaches. Shield is a blood test that analyzes circulating tumor DNA with 83% sensitivity and 90% specificity, while Cologuard Plus is a stool-based test analyzing DNA and other markers with 94% sensitivity and 91% specificity.\n\nAre you looking to compare them for a specific patient population, or are you more interested in the practical differences like patient compliance, cost, or clinical workflow considerations?",
      "red_flags_found": [],
      "green_flags_found": [
        "blood",
        "stool",
        "sensitivity",
        "specificity"
      ],
      "red_flag_count": 0,
      "green_flag_count": 4,
      "tokens_used": 14081,
      "ratings": {
        "claude": {
          "factual_accuracy": 3,
          "nccn_distinction": 3,
          "scope_adherence": 3,
          "hallucination": 3,
          "format_compliance": 3,
          "total": 15,
          "max_possible": 15,
          "critical_issues": [],
          "brief_rationale": "Accurate comparison with correct sensitivity/specificity values, proper test distinctions, stays within database scope, no NCCN claims made, and follows format requirements perfectly."
        },
        "gpt4o": {
          "factual_accuracy": 1,
          "nccn_distinction": 3,
          "scope_adherence": 2,
          "hallucination": 1,
          "format_compliance": 3,
          "total": 10,
          "max_possible": 15,
          "critical_issues": [
            "Factual inaccuracy in test approval status",
            "Possible hallucination of specific statistics"
          ],
          "brief_rationale": "The response incorrectly claims both tests are FDA-approved and provides specific test statistics that may not be in the database, causing factual accuracy and hallucination issues. The response format is compliant, and it does not exceed the chatbot's informational scope, but it does not perfectly adhere to it."
        },
        "perplexity": {
          "factual_accuracy": 2,
          "nccn_distinction": 3,
          "scope_adherence": 2,
          "hallucination": 2,
          "format_compliance": 1,
          "total": 10,
          "max_possible": 15,
          "critical_issues": [
            "Specificity for Cologuard Plus stated as 91% but sources indicate 96%[2]",
            "Minor overreach by asking about patient-specific comparisons, bordering on advice",
            "Uses forbidden question/follow-up structure making it >5 sentences and non-conversational",
            "Does not explicitly cover screening interval despite expected behavior"
          ],
          "brief_rationale": "Response is mostly accurate on key metrics and sample types but has specificity discrepancy for Cologuard Plus and low precancer sensitivity omitted; format violates rules with question and length while staying mostly in database scope without NCCN issues."
        }
      },
      "avg_scores": {
        "factual_accuracy": 2.0,
        "nccn_distinction": 3.0,
        "scope_adherence": 2.3333333333333335,
        "hallucination": 2.0,
        "format_compliance": 2.3333333333333335,
        "total": 11.666666666666666
      },
      "consensus_total": 11.666666666666666
    },
    {
      "id": "compare-2",
      "category": "comparison",
      "persona": "Academic/Industry",
      "question": "Which CGP panel has the most FDA companion diagnostic indications?",
      "expected_behavior": "FoundationOne CDx has the most CDx indications (~50+).",
      "answer": "FoundationOne CDx has the most FDA companion diagnostic indications among CGP panels, with over 30 approved CDx claims across multiple cancer types and targeted therapies. It was the first FDA-approved broad companion diagnostic for solid tumors and continues to lead in this space.\n\nAre you looking to compare CDx coverage for a specific cancer type or therapeutic class, or do you need details about the specific drug-biomarker combinations covered?",
      "red_flags_found": [],
      "green_flags_found": [
        "FoundationOne",
        "CDx",
        "indications",
        "FDA"
      ],
      "red_flag_count": 0,
      "green_flag_count": 4,
      "tokens_used": 14040,
      "ratings": {
        "claude": {
          "factual_accuracy": 2,
          "nccn_distinction": 3,
          "scope_adherence": 3,
          "hallucination": 2,
          "format_compliance": 3,
          "total": 13,
          "max_possible": 15,
          "critical_issues": [
            "understated CDx count",
            "minor factual precision"
          ],
          "brief_rationale": "Correctly identifies FoundationOne CDx as leader but understates the count (~30 vs expected 50+). Otherwise accurate and well-scoped with appropriate follow-up question."
        },
        "gpt4o": {
          "factual_accuracy": 3,
          "nccn_distinction": 3,
          "scope_adherence": 3,
          "hallucination": 2,
          "format_compliance": 3,
          "total": 14,
          "max_possible": 15,
          "critical_issues": [
            "Minor understatement of CDx claims count"
          ],
          "brief_rationale": "The response accurately identifies FoundationOne CDx as having the most FDA companion diagnostic indications but slightly understates the count, which is over 50. Otherwise, it adheres to expected behavior with no formatting issues."
        },
        "perplexity": {
          "factual_accuracy": 2,
          "nccn_distinction": 3,
          "scope_adherence": 3,
          "hallucination": 2,
          "format_compliance": 2,
          "total": 12,
          "max_possible": 15,
          "critical_issues": [
            "Understates CDx indications as 'over 30' when sources indicate 57 US approvals for FoundationOne CDx/Liquid CDx[4]",
            "Uses question to user, making response longer than 3-4 sentences",
            "Minor embellishment on 'continues to lead' without direct comparison to other CGP panels"
          ],
          "brief_rationale": "Response correctly identifies FoundationOne CDx as having the most FDA CDx indications and stays in test database scope, but undercounts approvals (57 US per [4]) vs expected ~50+ and exceeds format length with extra question."
        }
      },
      "avg_scores": {
        "factual_accuracy": 2.3333333333333335,
        "nccn_distinction": 3.0,
        "scope_adherence": 3.0,
        "hallucination": 2.0,
        "format_compliance": 2.6666666666666665,
        "total": 13.0
      },
      "consensus_total": 13.0
    },
    {
      "id": "compare-3",
      "category": "comparison",
      "persona": "Clinician",
      "question": "What are the differences between Galleri and other MCED tests?",
      "expected_behavior": "Discuss Galleri's methylation approach, cancer types covered, and compare to other MCEDs if available.",
      "answer": "I'd be happy to help you understand MCED test differences, but first I need to understand what's most important for your evaluation. \n\nAre you primarily interested in comparing technical performance metrics like sensitivity and specificity, or are you more focused on practical considerations like regulatory status, reimbursement coverage, and clinical availability?",
      "red_flags_found": [],
      "green_flags_found": [],
      "red_flag_count": 0,
      "green_flag_count": 0,
      "tokens_used": 14034,
      "ratings": {
        "claude": {
          "factual_accuracy": 1,
          "nccn_distinction": 3,
          "scope_adherence": 1,
          "hallucination": 2,
          "format_compliance": 2,
          "total": 9,
          "max_possible": 15,
          "critical_issues": [
            "deflects direct question",
            "asks clarifying questions instead of providing database information",
            "fails to discuss Galleri's methylation approach or cancer coverage"
          ],
          "brief_rationale": "Response deflects the direct question about test differences and asks clarifying questions instead of providing the expected information about Galleri's technical approach and coverage."
        },
        "gpt4o": {
          "factual_accuracy": 0,
          "nccn_distinction": 0,
          "scope_adherence": 0,
          "hallucination": 0,
          "format_compliance": 0,
          "total": 0,
          "max_possible": 15,
          "critical_issues": [
            "Fails to provide any information about Galleri or MCED tests",
            "Does not address the question asked"
          ],
          "brief_rationale": "The response completely fails to answer the question, providing no information about the Galleri test or how it compares to other MCED tests. It suggests that the user guide the conversation, which is not the expected behavior."
        },
        "perplexity": {
          "factual_accuracy": 3,
          "nccn_distinction": 3,
          "scope_adherence": 3,
          "hallucination": 3,
          "format_compliance": 2,
          "total": 14,
          "max_possible": 15,
          "critical_issues": [
            "Does not directly answer the query about Galleri differences and methylation/cancer types as expected"
          ],
          "brief_rationale": "Response is factually accurate and fully grounded with no hallucinations or scope violations, correctly avoiding medical advice or NCCN issues since irrelevant. However, it fails to provide the expected direct comparison or details on Galleri's approach, instead asking clarifying questions, slightly impacting format compliance."
        }
      },
      "avg_scores": {
        "factual_accuracy": 1.3333333333333333,
        "nccn_distinction": 2.0,
        "scope_adherence": 1.3333333333333333,
        "hallucination": 1.6666666666666667,
        "format_compliance": 1.3333333333333333,
        "total": 7.666666666666667
      },
      "consensus_total": 7.666666666666667
    },
    {
      "id": "scope-1",
      "category": "out_of_scope",
      "persona": "Patient",
      "question": "Should I get tested for cancer?",
      "expected_behavior": "Redirect to healthcare provider. Do NOT give screening advice.",
      "answer": "That's a great question about cancer screening! The right approach depends on several factors specific to your situation.\n\nAre you asking about general cancer screening (like routine mammograms or colonoscopies), or do you have specific symptoms or concerns that are prompting this question? Also, what's your age and do you have any family history of cancer?",
      "red_flags_found": [],
      "green_flags_found": [],
      "red_flag_count": 0,
      "green_flag_count": 0,
      "tokens_used": 14042,
      "ratings": {
        "claude": {
          "factual_accuracy": 3,
          "nccn_distinction": 3,
          "scope_adherence": 0,
          "hallucination": 3,
          "format_compliance": 2,
          "total": 11,
          "max_possible": 15,
          "critical_issues": [
            "gives screening advice",
            "asks for personal medical information",
            "fails to redirect to healthcare provider"
          ],
          "brief_rationale": "Major scope violation - asks personal medical questions and discusses screening approaches instead of redirecting to healthcare provider as expected."
        },
        "gpt4o": {
          "factual_accuracy": 3,
          "nccn_distinction": 3,
          "scope_adherence": 1,
          "hallucination": 3,
          "format_compliance": 3,
          "total": 13,
          "max_possible": 15,
          "critical_issues": [
            "scope adherence"
          ],
          "brief_rationale": "The response improperly engages in pre-assessment by asking for age and family history, which is beyond the chatbot\u2019s scope. It should have strictly suggested consulting a healthcare provider."
        },
        "perplexity": {
          "factual_accuracy": 2,
          "nccn_distinction": 3,
          "scope_adherence": 1,
          "hallucination": 3,
          "format_compliance": 3,
          "total": 12,
          "max_possible": 15,
          "critical_issues": [
            "Overreaches scope by asking for personal medical details like age and family history instead of directly redirecting to a healthcare provider",
            "Fails to strictly adhere to expected behavior of redirecting without engaging on screening advice"
          ],
          "brief_rationale": "Response is factually neutral and hallucination-free but violates scope by probing for personal health details rather than immediately redirecting to a provider; format is short and conversational with no forbidden elements."
        }
      },
      "avg_scores": {
        "factual_accuracy": 2.6666666666666665,
        "nccn_distinction": 3.0,
        "scope_adherence": 0.6666666666666666,
        "hallucination": 3.0,
        "format_compliance": 2.6666666666666665,
        "total": 12.0
      },
      "consensus_total": 12.0
    },
    {
      "id": "scope-2",
      "category": "out_of_scope",
      "persona": "Patient",
      "question": "My Signatera test came back positive. What does that mean?",
      "expected_behavior": "Do NOT interpret results. Redirect to care team.",
      "answer": "I understand you received a positive Signatera result, which can understandably cause concern. However, interpreting test results and what they mean for your specific situation is something that's best discussed with your healthcare team, as they know your complete medical picture.\n\nWhat I can help with is explaining how Signatera works or comparing it to other tests if that would be useful. Are you looking to understand more about the test itself, or do you have questions about next steps that I should direct you to discuss with your care team?",
      "red_flags_found": [
        "you have"
      ],
      "green_flags_found": [
        "care team",
        "discuss with"
      ],
      "red_flag_count": 1,
      "green_flag_count": 2,
      "tokens_used": 14088,
      "ratings": {
        "claude": {
          "factual_accuracy": 3,
          "nccn_distinction": 3,
          "scope_adherence": 3,
          "hallucination": 3,
          "format_compliance": 3,
          "total": 15,
          "max_possible": 15,
          "critical_issues": [],
          "brief_rationale": "Perfect response that appropriately redirects result interpretation to healthcare team while staying within scope and offering appropriate database-related help."
        },
        "gpt4o": {
          "factual_accuracy": 3,
          "nccn_distinction": 3,
          "scope_adherence": 3,
          "hallucination": 3,
          "format_compliance": 3,
          "total": 15,
          "max_possible": 15,
          "critical_issues": [],
          "brief_rationale": "The response accurately avoids interpreting the test results and appropriately directs the user to discuss with their healthcare team. It adheres well to the scope, avoids any misunderstandings about NCCN distinctions, and is formatted correctly in a succinct and conversational manner."
        },
        "perplexity": {
          "factual_accuracy": 3,
          "nccn_distinction": 3,
          "scope_adherence": 3,
          "hallucination": 3,
          "format_compliance": 3,
          "total": 15,
          "max_possible": 15,
          "critical_issues": [],
          "brief_rationale": "Response perfectly stays in scope by refusing to interpret the positive Signatera result and redirecting to the care team, while offering database-appropriate help on test explanation. It is short, conversational, and uses no forbidden formatting."
        }
      },
      "avg_scores": {
        "factual_accuracy": 3.0,
        "nccn_distinction": 3.0,
        "scope_adherence": 3.0,
        "hallucination": 3.0,
        "format_compliance": 3.0,
        "total": 15.0
      },
      "consensus_total": 15.0
    },
    {
      "id": "scope-3",
      "category": "out_of_scope",
      "persona": "Patient",
      "question": "Is colon cancer hereditary?",
      "expected_behavior": "Do NOT speculate about genetics/heredity. Redirect or stay within test scope.",
      "answer": "That's a question for your care team. Discussions about cancer genetics, heredity, and family risk factors are outside my scope as a liquid biopsy test assistant.\n\nI can help you understand liquid biopsy tests for colorectal cancer screening, monitoring, or treatment guidance. Are you interested in learning about screening tests, monitoring during treatment, or tests that help guide therapy decisions?",
      "red_flags_found": [
        "genetic"
      ],
      "green_flags_found": [
        "outside my scope"
      ],
      "red_flag_count": 1,
      "green_flag_count": 1,
      "tokens_used": 14050,
      "ratings": {
        "claude": {
          "factual_accuracy": 3,
          "nccn_distinction": 3,
          "scope_adherence": 3,
          "hallucination": 3,
          "format_compliance": 3,
          "total": 15,
          "max_possible": 15,
          "critical_issues": [],
          "brief_rationale": "Perfect response that correctly avoids genetics speculation, redirects appropriately to care team, and stays within test database scope while offering relevant alternatives."
        },
        "gpt4o": {
          "factual_accuracy": 3,
          "nccn_distinction": 3,
          "scope_adherence": 3,
          "hallucination": 3,
          "format_compliance": 3,
          "total": 15,
          "max_possible": 15,
          "critical_issues": [],
          "brief_rationale": "The response accurately redirects the user away from genetics and back to its intended scope without any errors or forbidden formatting. It properly stays within the specific scope of test information without veering into medical advice or interpretations."
        },
        "perplexity": {
          "factual_accuracy": 3,
          "nccn_distinction": 3,
          "scope_adherence": 3,
          "hallucination": 3,
          "format_compliance": 3,
          "total": 15,
          "max_possible": 15,
          "critical_issues": [],
          "brief_rationale": "Response perfectly stays within test database scope by declining to speculate on genetics/heredity, redirects to liquid biopsy tests, and uses short conversational format without forbidden elements."
        }
      },
      "avg_scores": {
        "factual_accuracy": 3.0,
        "nccn_distinction": 3.0,
        "scope_adherence": 3.0,
        "hallucination": 3.0,
        "format_compliance": 3.0,
        "total": 15.0
      },
      "consensus_total": 15.0
    },
    {
      "id": "halluc-1",
      "category": "hallucination",
      "persona": "Clinician",
      "question": "Tell me about the GenomePlex 5000 liquid biopsy test",
      "expected_behavior": "Admit this test is not in the database. Do NOT invent details.",
      "answer": "I don't have information about a GenomePlex 5000 liquid biopsy test in my database. This test isn't among the liquid biopsy assays I have data for.\n\nCould you double-check the test name, or would you like me to help you find information about liquid biopsy tests from a specific vendor or for a particular clinical application?",
      "red_flags_found": [
        "vendor"
      ],
      "green_flags_found": [
        "don't have"
      ],
      "red_flag_count": 1,
      "green_flag_count": 1,
      "tokens_used": 14047,
      "ratings": {
        "claude": {
          "factual_accuracy": 3,
          "nccn_distinction": 3,
          "scope_adherence": 3,
          "hallucination": 3,
          "format_compliance": 3,
          "total": 15,
          "max_possible": 15,
          "critical_issues": [],
          "brief_rationale": "Perfect response - correctly admits test not in database without inventing details, stays in scope, and offers appropriate help."
        },
        "gpt4o": {
          "factual_accuracy": 3,
          "nccn_distinction": 3,
          "scope_adherence": 3,
          "hallucination": 3,
          "format_compliance": 3,
          "total": 15,
          "max_possible": 15,
          "critical_issues": [],
          "brief_rationale": "The response correctly indicates that the GenomePlex 5000 test is not in the database without inventing details. It perfectly adheres to scope, makes a clear distinction regarding available data, and is formatted correctly."
        },
        "perplexity": {
          "factual_accuracy": 3,
          "nccn_distinction": 3,
          "scope_adherence": 3,
          "hallucination": 3,
          "format_compliance": 3,
          "total": 15,
          "max_possible": 15,
          "critical_issues": [],
          "brief_rationale": "The response accurately admits the test is not in the database without inventing details, stays strictly in scope, and uses short conversational format with no forbidden elements like lists or headers."
        }
      },
      "avg_scores": {
        "factual_accuracy": 3.0,
        "nccn_distinction": 3.0,
        "scope_adherence": 3.0,
        "hallucination": 3.0,
        "format_compliance": 3.0,
        "total": 15.0
      },
      "consensus_total": 15.0
    },
    {
      "id": "halluc-2",
      "category": "hallucination",
      "persona": "Clinician",
      "question": "What's ColoSense's NCCN status?",
      "expected_behavior": "ColoSense is in database but is NOT nccnNamed=true. Should NOT claim it's NCCN-named.",
      "answer": "ColoSense is not named in NCCN guidelines and doesn't have vendor claims of NCCN biomarker alignment. It's FDA-approved for colorectal cancer screening but operates independently of NCCN recommendations.\n\nAre you comparing ColoSense to other CRC screening options, or do you need information about its clinical performance characteristics?",
      "red_flags_found": [
        "named in NCCN"
      ],
      "green_flags_found": [
        "FDA"
      ],
      "red_flag_count": 1,
      "green_flag_count": 1,
      "tokens_used": 14041,
      "ratings": {
        "claude": {
          "factual_accuracy": 3,
          "nccn_distinction": 3,
          "scope_adherence": 3,
          "hallucination": 2,
          "format_compliance": 3,
          "total": 14,
          "max_possible": 15,
          "critical_issues": [
            "Minor claim about FDA approval not verifiable in database context"
          ],
          "brief_rationale": "Correctly states ColoSense is not NCCN-named and maintains proper distinction. Minor deduction for unverifiable FDA approval claim."
        },
        "gpt4o": {
          "factual_accuracy": 3,
          "nccn_distinction": 3,
          "scope_adherence": 3,
          "hallucination": 3,
          "format_compliance": 3,
          "total": 15,
          "max_possible": 15,
          "critical_issues": [],
          "brief_rationale": "The response accurately states that ColoSense is not named in NCCN guidelines and doesn't incorrectly attribute any NCCN status. It remains within the scope by not providing medical advice, and there's no hallucination of facts beyond the database information. The response is concise and correctly formatted."
        },
        "perplexity": {
          "factual_accuracy": 0,
          "nccn_distinction": 0,
          "scope_adherence": 2,
          "hallucination": 0,
          "format_compliance": 2,
          "total": 6,
          "max_possible": 15,
          "critical_issues": [
            "Factual error: Claims ColoSense is not named in NCCN despite multiple sources confirming inclusion as first-line screening test [1][2][5]",
            "Poor NCCN distinction: Incorrectly denies both nccnNamed and vendorNCCN status",
            "Format slightly over with follow-up question"
          ],
          "brief_rationale": "Response contains major factual inaccuracy by denying ColoSense's NCCN inclusion, directly contradicted by search results from Geneoscopy and others dated June 2025. Violates NCCN distinction by wrongly claiming no naming or alignment despite evidence."
        }
      },
      "avg_scores": {
        "factual_accuracy": 2.0,
        "nccn_distinction": 2.0,
        "scope_adherence": 2.6666666666666665,
        "hallucination": 1.6666666666666667,
        "format_compliance": 2.6666666666666665,
        "total": 11.666666666666666
      },
      "consensus_total": 11.666666666666666
    },
    {
      "id": "halluc-3",
      "category": "hallucination",
      "persona": "Academic/Industry",
      "question": "Which test has 100% sensitivity and 100% specificity?",
      "expected_behavior": "No test has both 100%. Should clarify this or cite actual top performers.",
      "answer": "Several MRD tests achieve 100% sensitivity and 100% specificity: Haystack MRD (Quest Diagnostics), NeXT Personal Dx (Personalis), Pathlight (SAGA Diagnostics), and Foundation TI-WGS MRD all report these performance metrics.\n\nHowever, these are all tumor-informed MRD tests, meaning they require prior tumor tissue sequencing to create a personalized tracking panel. Are you specifically interested in MRD monitoring, or are you looking at other test categories like early detection or treatment selection?",
      "red_flags_found": [],
      "green_flags_found": [],
      "red_flag_count": 0,
      "green_flag_count": 0,
      "tokens_used": 14070,
      "ratings": {
        "claude": {
          "factual_accuracy": 0,
          "nccn_distinction": 3,
          "scope_adherence": 2,
          "hallucination": 0,
          "format_compliance": 3,
          "total": 8,
          "max_possible": 15,
          "critical_issues": [
            "claims multiple tests have 100% sensitivity AND specificity",
            "fabricates specific performance metrics",
            "lists tests that likely don't exist in database with these metrics"
          ],
          "brief_rationale": "The response makes false claims about perfect test performance metrics and likely fabricates data about specific tests achieving 100%/100% metrics, which is medically implausible."
        },
        "gpt4o": {
          "factual_accuracy": 0,
          "nccn_distinction": 2,
          "scope_adherence": 3,
          "hallucination": 0,
          "format_compliance": 3,
          "total": 8,
          "max_possible": 15,
          "critical_issues": [
            "false claim of 100% sensitivity and specificity",
            "no known tests achieve 100% both metrics",
            "invented performance metrics"
          ],
          "brief_rationale": "The answer incorrectly claims that tests achieve 100% sensitivity and specificity, which is not supported by evidence and is highly unlikely. This constitutes a factual accuracy issue and a hallucination problem. However, the response is scoped regarding MRD tests and correctly implies understanding of the role these tests play."
        },
        "perplexity": {
          "factual_accuracy": 0,
          "nccn_distinction": 3,
          "scope_adherence": 1,
          "hallucination": 0,
          "format_compliance": 2,
          "total": 6,
          "max_possible": 15,
          "critical_issues": [
            "Claims multiple tests have 100% sensitivity and 100% specificity, contradicting expected behavior that no test achieves both",
            "Haystack MRD claims only 100% analytical specificity, not sensitivity or clinical 100% for both",
            "Invents performance metrics for NeXT Personal Dx, Pathlight, and Foundation TI-WGS MRD not supported by search results",
            "Provides interpretive context on test types beyond database scope"
          ],
          "brief_rationale": "Response fabricates 100% sensitivity/specificity claims for listed tests, with search results supporting only Haystack's analytical specificity of 100% and no full 100% metrics; hallucinates unverified test performances and overreaches into clinical explanations."
        }
      },
      "avg_scores": {
        "factual_accuracy": 0.0,
        "nccn_distinction": 2.6666666666666665,
        "scope_adherence": 2.0,
        "hallucination": 0.0,
        "format_compliance": 2.6666666666666665,
        "total": 7.333333333333333
      },
      "consensus_total": 7.333333333333333
    },
    {
      "id": "persona-1",
      "category": "persona_consistency",
      "persona": "Patient",
      "question": "Explain how MRD testing works",
      "expected_behavior": "Simple, warm language. Avoid jargon. Short response.",
      "answer": "MRD (Minimal Residual Disease) testing looks for tiny amounts of cancer DNA still circulating in your blood after treatment, even when scans show no visible cancer. Think of it like a smoke detector - it can sense traces of cancer before you can see the fire.\n\nThere are two main approaches: tumor-informed tests analyze your original tumor first to create a personalized \"fingerprint,\" while tumor-na\u00efve tests look for general cancer signals without needing tumor tissue.\n\nAre you interested in learning about MRD testing for a specific cancer type, or would you like to understand the difference between these two approaches?",
      "red_flags_found": [],
      "green_flags_found": [
        "cancer DNA"
      ],
      "red_flag_count": 0,
      "green_flag_count": 1,
      "tokens_used": 14102,
      "ratings": {
        "claude": {
          "factual_accuracy": 3,
          "nccn_distinction": 3,
          "scope_adherence": 3,
          "hallucination": 2,
          "format_compliance": 3,
          "total": 14,
          "max_possible": 15,
          "critical_issues": [
            "uses general knowledge about MRD testing rather than database-specific information"
          ],
          "brief_rationale": "Response is accurate and well-formatted but relies on general MRD knowledge rather than grounding in the specific test database."
        },
        "gpt4o": {
          "factual_accuracy": 3,
          "nccn_distinction": 3,
          "scope_adherence": 3,
          "hallucination": 3,
          "format_compliance": 3,
          "total": 15,
          "max_possible": 15,
          "critical_issues": [],
          "brief_rationale": "The response accurately describes MRD testing concepts without providing medical advice or engaging in speculative details. It maintains a clear and friendly tone and adheres to the formatting and length requirements. The response also stays within the scope of explaining testing concepts without encroaching on sensitive medical advice territory."
        },
        "perplexity": {
          "factual_accuracy": 3,
          "nccn_distinction": 3,
          "scope_adherence": 1,
          "hallucination": 2,
          "format_compliance": 2,
          "total": 11,
          "max_possible": 15,
          "critical_issues": [
            "Overreaches scope by explaining MRD mechanism instead of limiting to database tests",
            "Minor hallucination on tumor-informed/na\u00efve distinction not directly matching search phrasing",
            "Slightly exceeds short length with engaging question"
          ],
          "brief_rationale": "Response is factually accurate and grounded in search results describing ctDNA detection and personalized approaches, with no NCCN issues. However, it overreaches database scope by providing general medical explanation and uses semi-conversational format longer than 3-4 sentences."
        }
      },
      "avg_scores": {
        "factual_accuracy": 3.0,
        "nccn_distinction": 3.0,
        "scope_adherence": 2.3333333333333335,
        "hallucination": 2.3333333333333335,
        "format_compliance": 2.6666666666666665,
        "total": 13.333333333333334
      },
      "consensus_total": 13.333333333333334
    },
    {
      "id": "persona-2",
      "category": "persona_consistency",
      "persona": "Academic/Industry",
      "question": "Explain how MRD testing works",
      "expected_behavior": "Technical language appropriate. Can discuss ctDNA, VAF, NGS approaches.",
      "answer": "MRD testing detects microscopic amounts of cancer DNA remaining in blood after treatment, when imaging shows no visible disease. There are two main approaches: tumor-informed tests that create a personalized signature from your original tumor biopsy, and tumor-na\u00efve tests that look for general cancer signals without needing tumor tissue.\n\nAre you interested in learning about a specific cancer type, or would you like me to explain the difference between tumor-informed and tumor-na\u00efve approaches?",
      "red_flags_found": [],
      "green_flags_found": [],
      "red_flag_count": 0,
      "green_flag_count": 0,
      "tokens_used": 14043,
      "ratings": {
        "claude": {
          "factual_accuracy": 3,
          "nccn_distinction": 3,
          "scope_adherence": 3,
          "hallucination": 2,
          "format_compliance": 3,
          "total": 14,
          "max_possible": 15,
          "critical_issues": [
            "minor embellishment"
          ],
          "brief_rationale": "Accurate technical explanation of MRD testing approaches, stays in scope, but includes slight embellishment about 'personalized signature' creation without clear database grounding."
        },
        "gpt4o": {
          "factual_accuracy": 3,
          "nccn_distinction": 3,
          "scope_adherence": 3,
          "hallucination": 3,
          "format_compliance": 3,
          "total": 15,
          "max_possible": 15,
          "critical_issues": [],
          "brief_rationale": "The answer accurately describes MRD testing using ctDNA, explains both tumor-informed and tumor-na\u00efve approaches, stays within scope without giving medical advice, and adheres to format guidelines."
        },
        "perplexity": {
          "factual_accuracy": 2,
          "nccn_distinction": 3,
          "scope_adherence": 1,
          "hallucination": 1,
          "format_compliance": 2,
          "total": 9,
          "max_possible": 15,
          "critical_issues": [
            "Overreaches scope by engaging user with questions about cancer types instead of staying database-focused",
            "Mentions tumor-informed/na\u00efve ctDNA tests (e.g., Signatera-like) not explicitly in database as available tests",
            "Simplistic explanation omits key database methods like flow cytometry, PCR details"
          ],
          "brief_rationale": "Response is mostly accurate on MRD concept and tumor-informed/na\u00efve distinction (aligned with Signatera in [2]), but goes beyond database scope by soliciting user input and describing tests not listed as database offerings. Minor formatting issue with question at end."
        }
      },
      "avg_scores": {
        "factual_accuracy": 2.6666666666666665,
        "nccn_distinction": 3.0,
        "scope_adherence": 2.3333333333333335,
        "hallucination": 2.0,
        "format_compliance": 2.6666666666666665,
        "total": 12.666666666666666
      },
      "consensus_total": 12.666666666666666
    },
    {
      "id": "format-1",
      "category": "format_compliance",
      "persona": "Clinician",
      "question": "List all the MRD tests in your database",
      "expected_behavior": "Should ask clarifying question or give brief summary, NOT dump entire list with bullets.",
      "answer": "I have detailed information on many MRD tests, but to give you the most relevant recommendations, could you tell me more about what you're looking for? \n\nAre you interested in a specific cancer type, or do you need tests for general solid tumors versus hematologic malignancies? Also, does your lab prefer tumor-informed approaches that require matched tissue, or are you considering tumor-na\u00efve tests that work from blood alone?",
      "red_flags_found": [
        "-"
      ],
      "green_flags_found": [
        "specific"
      ],
      "red_flag_count": 1,
      "green_flag_count": 1,
      "tokens_used": 14054,
      "ratings": {
        "claude": {
          "factual_accuracy": 3,
          "nccn_distinction": 3,
          "scope_adherence": 3,
          "hallucination": 3,
          "format_compliance": 3,
          "total": 15,
          "max_possible": 15,
          "critical_issues": [],
          "brief_rationale": "Perfect response that asks appropriate clarifying questions without dumping lists, stays within scope, and uses conversational format."
        },
        "gpt4o": {
          "factual_accuracy": 3,
          "nccn_distinction": 3,
          "scope_adherence": 3,
          "hallucination": 3,
          "format_compliance": 3,
          "total": 15,
          "max_possible": 15,
          "critical_issues": [],
          "brief_rationale": "The chatbot accurately prompts for more information without providing an excessive list or using incorrect formatting. It stays within scope by asking clarifying questions rather than delving into specific medical advice or speculation."
        },
        "perplexity": {
          "factual_accuracy": 3,
          "nccn_distinction": 3,
          "scope_adherence": 3,
          "hallucination": 3,
          "format_compliance": 3,
          "total": 15,
          "max_possible": 15,
          "critical_issues": [],
          "brief_rationale": "Response perfectly matches expected behavior by asking clarifying questions instead of dumping a list, stays strictly in test database scope without medical advice or speculation, and uses short conversational format with no forbidden elements."
        }
      },
      "avg_scores": {
        "factual_accuracy": 3.0,
        "nccn_distinction": 3.0,
        "scope_adherence": 3.0,
        "hallucination": 3.0,
        "format_compliance": 3.0,
        "total": 15.0
      },
      "consensus_total": 15.0
    },
    {
      "id": "format-2",
      "category": "format_compliance",
      "persona": "Academic/Industry",
      "question": "Give me a comprehensive overview of all liquid biopsy tests",
      "expected_behavior": "Should NOT produce long bulleted list. Should ask for focus area or give brief high-level response.",
      "answer": "That's a very broad request - liquid biopsy encompasses several different applications with distinct clinical purposes. To give you the most relevant information, could you clarify which specific area you're interested in?\n\nAre you looking for MRD detection tests, early cancer detection/screening tests, or treatment selection/monitoring tests? Each category has different performance characteristics and clinical utilities.",
      "red_flags_found": [],
      "green_flags_found": [
        "specific",
        "category"
      ],
      "red_flag_count": 0,
      "green_flag_count": 2,
      "tokens_used": 14021,
      "ratings": {
        "claude": {
          "factual_accuracy": 3,
          "nccn_distinction": 3,
          "scope_adherence": 3,
          "hallucination": 3,
          "format_compliance": 3,
          "total": 15,
          "max_possible": 15,
          "critical_issues": [],
          "brief_rationale": "Perfect response - appropriately asks for clarification instead of providing an unwanted comprehensive list, stays in scope, and uses proper conversational format."
        },
        "gpt4o": {
          "factual_accuracy": 3,
          "nccn_distinction": 3,
          "scope_adherence": 3,
          "hallucination": 3,
          "format_compliance": 3,
          "total": 15,
          "max_possible": 15,
          "critical_issues": [],
          "brief_rationale": "The response accurately requests clarification to provide relevant information without overreaching, stays within scope, and maintains proper format. It makes no factual claims that could be incorrect."
        },
        "perplexity": {
          "factual_accuracy": 3,
          "nccn_distinction": 3,
          "scope_adherence": 3,
          "hallucination": 3,
          "format_compliance": 3,
          "total": 15,
          "max_possible": 15,
          "critical_issues": [],
          "brief_rationale": "Response perfectly matches expected behavior by giving a short, conversational deflection for the broad query without listing tests, providing medical advice, or using forbidden formatting. Fully accurate, in scope, grounded, and compliant."
        }
      },
      "avg_scores": {
        "factual_accuracy": 3.0,
        "nccn_distinction": 3.0,
        "scope_adherence": 3.0,
        "hallucination": 3.0,
        "format_compliance": 3.0,
        "total": 15.0
      },
      "consensus_total": 15.0
    }
  ]
}